The tumor immune landscape can be categorized into six subtypes: wound healing (C1), IFN-g dominant (C2), inflammatory (C3), lymphocyte-depleted (C4), immunologically quiet (C5), and TGF-b dominant (C6) (Thorsson et al., 2018). The gene discussed is TGFB1; the disease is neoplasm.